Headline News about Intellia Thera CS
![](https://cdn.benzinga.com/files/images/story/2023/06/12/ntla.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/10/ccl1600-1024x576.png)
![](https://investorplace.com/wp-content/uploads/2020/07/alzheimers-memory-loss.jpg)
![](https://investorplace.com/wp-content/uploads/2022/12/ntla-stock.jpg)
![](https://www.investors.com/wp-content/uploads/2017/12/Stock-Biotech-11-Adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/06/12/dna-gb1242460d_1280.jpg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/735588/growth-chart.jpg)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Intellia Therapeutics: Q1 Earnings Insights
May 04, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/06/12/chinook_therapeutics_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/734891/gettyimages-968838136.jpg)
![](https://g.foolcdn.com/editorial/images/731107/dna-on-monitor-scientists.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/05/04/ntla.png?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Intellia Therapeutics's Earnings Outlook
May 03, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/02/crispr-genetic-editing.jpg)
![](/next-assets/images/schema-image-default.png)
Where Intellia Therapeutics Stands With Analysts
March 31, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/729977/gettyimages-1290369115.jpg)
![](https://investorplace.com/wp-content/uploads/2019/07/biotech1600-1.jpg)
![](https://investorplace.com/wp-content/uploads/2021/03/growth-stocks-1600.jpg)
![](https://g.foolcdn.com/editorial/images/727560/a-couple-of-investors-looking-at-a-series-of-charts.jpg)
![](https://investorplace.com/wp-content/uploads/2020/03/gene_editing_c_1600.jpg)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/04/13/image_4.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/ARK_Photo_by_Ira_Lichi_on_Shutterstock.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600.png)
![](https://investorplace.com/wp-content/uploads/2021/01/crispr-stocks.jpg)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://g.foolcdn.com/editorial/images/724894/scientists-in-a-lab-smiling.jpg)
![](https://g.foolcdn.com/editorial/images/723427/dna-on-monitor-scientists.jpg)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.